Determine the necessary mass, volume, or concentration for preparing a solution.
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
SKU | Size | Availability | Price | Qty |
---|---|---|---|---|
L107709-1g | 1g | In stock | $14.90 | |
L107709-5g | 5g | In stock | $57.90 | |
L107709-25g | 25g | In stock | $219.90 | |
L107709-100g | 100g | In stock | $790.90 |
Potent HMG-CoA reductase inhibitor
Synonyms | lovastatin|75330-75-5|mevinolin|Mevacor|Altoprev|Mevlor|Sivlor|Lovalord|Nergadan|Altocor|Artein|MK-803|Monacolin K|Cholestra|Closterol|Hipovastin|Lestatin|Lipofren|Lovasterol|Lovastin|Tecnolip|Teroltrat|6alpha-Methylcompactin|Belvas|Colevix|Hipolip|Lipdip |
---|---|
Specifications & Purity | 98% |
Storage Temp | Protected from light,Store at -20°C,Argon charged |
Shipped In | Dry ice |
Grade | Moligand™ |
Action Type | AGONIST, INHIBITOR |
Mechanism of action | HMG-CoA reductase inhibitor |
ALogP | 4.3 |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
IUPAC Name | [(1S,3R,7S,8S,8aR)-8-[2-[(2R,4R)-4-hydroxy-6-oxooxan-2-yl]ethyl]-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl] (2S)-2-methylbutanoate |
---|---|
INCHI | InChI=1S/C24H36O5/c1-5-15(3)24(27)29-21-11-14(2)10-17-7-6-16(4)20(23(17)21)9-8-19-12-18(25)13-22(26)28-19/h6-7,10,14-16,18-21,23,25H,5,8-9,11-13H2,1-4H3/t14-,15-,16-,18+,19+,20-,21-,23-/m0/s1 |
InChi Key | PCZOHLXUXFIOCF-BXMDZJJMSA-N |
Canonical SMILES | CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C |
Isomeric SMILES | CC[C@H](C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C |
WGK Germany | 3 |
RTECS | EK7907000 |
PubChem CID | 53232 |
Molecular Weight | 404.54 |
CAS Registry No. | 75330-75-5 |
---|---|
PubChem CID | 53232 |
DrugBank Ligand | DB00227 |
ChEBI | CHEBI:40303 |
Wikipedia | Lovastatin |
BindingDB Ligand | 34168 |
ChEMBL Ligand | CHEMBL503 |
NURSA Ligand | 10.1621/9W6AOGTCZU |
RCSB PDB Ligand | 803 |
PEP | lovastatin |
DrugCentral Ligand | 1612 |
Enter Lot Number to search for COA:
To view the certificate results,please click on a Lot number.For Lot numbers from past orders,please use our order status section
Lot Number | Certificate Type | Date | Item |
---|---|---|---|
A2423043 | Certificate of Analysis | Mar 15, 2022 | L107709 |
D2303495 | Certificate of Analysis | Mar 15, 2022 | L107709 |
F2207110 | Certificate of Analysis | Mar 15, 2022 | L107709 |
F2207111 | Certificate of Analysis | Mar 15, 2022 | L107709 |
F2207112 | Certificate of Analysis | Mar 15, 2022 | L107709 |
F2207113 | Certificate of Analysis | Mar 15, 2022 | L107709 |
L2307139 | Certificate of Analysis | Mar 15, 2022 | L107709 |
Solubility | Insoluble in water; Degree of Solubility in water: 0.4 mg/l 25 °C; Soluble in Ethanol,Methanol |
---|---|
Sensitivity | light sensitive |
Specific Rotation[α] | 320 ° (C=0.5, CH3CN) |
Melt Point(°C) | 175°C |
Pictogram(s) | GHS08, GHS07 |
---|---|
Signal | Danger |
Hazard Statements | H351:Suspected of causing cancer H302:Harmful if swallowed H317:May cause an allergic skin reaction H372:Causes damage to organs through prolonged or repeated exposure H361:Suspected of damaging fertility or the unborn child |
Precautionary Statements | P261:Avoid breathing dust/fume/gas/mist/vapors/spray. P280:Wear protective gloves/protective clothing/eye protection/face protection. P302+P352:IF ON SKIN: wash with plenty of water. P321:Specific treatment (see ... on this label). P405:Store locked up. P501:Dispose of contents/container to ... P264:Wash hands [and …] thoroughly after handling. P260:Do not breathe dust/fume/gas/mist/vapors/spray. P270:Do not eat, drink or smoke when using this product. P272:Contaminated work clothing should not be allowed out of the workplace. P333+P313:IF SKIN irritation or rash occurs: Get medical advice/attention. P362+P364:Take off contaminated clothing and wash it before reuse. P330:Rinse mouth. P203:Obtain, read and follow all safety instructions before use. P301+P317:IF SWALLOWED: Get medical help. P318:if exposed or concerned, get medical advice. P319:Get medical help if you feel unwell. |
WGK Germany | 3 |
RTECS | EK7907000 |
Merck Index | 5586 |
1. Choi HW, Shin PG, Lee JH, Choi WS, Kang MJ, Kong WS, Oh MJ, Seo YB, Kim GD. (2018) Anti-inflammatory effect of lovastatin is mediated via the modulation of NF-κB and inhibition of HDAC1 and the PI3K/Akt/mTOR pathway in RAW264.7 macrophages.. Int J Mol Med, 41 (2): (1103-1109). [PMID:29207042] |
2. Peng Y et al.. (2017) Lovastatin Inhibits Cancer Stem Cells and Sensitizes to Chemo- and Photodynamic Therapy in Nasopharyngeal Carcinoma.. J Cancer, 8 (9): (1655-1664). [PMID:28775785] |
3. Zheng C et al.. (2021) Lovastatin Inhibits EMT and Metastasis of Triple-Negative Breast Cancer Stem Cells Through Dysregulation of Cytoskeleton-Associated Proteins.. Front Oncol, 11 (656687). [PMID:34150623] |
4. Restivo G et al.. (2017) low neurotrophin receptor CD271 regulates phenotype switching in melanoma.. Nat Commun, 8 (1988). [PMID:29215016] |
5. Dorsch M et al.. (2021) Statins affect cancer cell plasticity with distinct consequences for tumor progression and metastasis.. Cell Rep, 37 (8): (110056). [PMID:34818551] |
6. Farfan-Morales CN et al.. (2021) The antiviral effect of metformin on zika and dengue virus infection.. Sci Rep, 11 (8743). [PMID:33888740] |
7. Canela A et al.. (2019) Topoisomerase II-Induced Chromosome Breakage and Translocation Is Determined by Chromosome Architecture and Transcriptional Activity.. Mol Cell, 75 (2): (252-266.e8). [PMID:31202577] |